Company Description
BioScience Health Innovations (OTC Link: BHIC) is a publicly traded pharmaceutical retailers company in the Healthcare sector. The company has a market capitalization of $22.0M.
BHIC stock has declined 45.2% over the past year. Shares last traded at $2.19.
On a trailing twelve-month basis, BioScience Health Innovations reported revenue of $1.8M with net income of $87K and diluted earnings per share of $0.00. The company operates at a net profit margin of 4.7%.
This page provides a comprehensive overview of BHIC stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
BioScience Health Innovations (BHIC) stock last traded at $2.19, up 9.65% from the previous close. Over the past 12 months, the stock has lost 45.2%. At a market capitalization of $22.0M, BHIC is classified as a micro-cap stock with approximately 11.0M shares outstanding.
Latest News
BioScience Health Innovations has 1 recent news article. Key topics include partnership. View all BHIC news →
SEC Filings
BioScience Health Innovations has filed 3 recent SEC filings, including 1 Form 1-A, 1 Form 10-Q, 1 Form 8-K. The most recent filing was submitted on November 25, 2025. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BHIC SEC filings →
Financial Highlights
BioScience Health Innovations generated $1.8M in revenue over the trailing twelve months, retaining a 70.9% gross margin, operating income reached $87K (4.7% operating margin), and net income was $87K, reflecting a 4.7% net profit margin. Diluted earnings per share stood at $0.00. The company generated $23K in operating cash flow.
Upcoming Events
Short Interest History
Days to Cover History
BHIC Company Profile & Sector Positioning
BioScience Health Innovations (BHIC) operates in the Pharmaceutical Retailers industry within the broader Healthcare sector and is listed on the OTC Link.